Lv6
2360 积分 2023-10-09 加入
China’s biotech boom: why the nation must collaborate to stay ahead
2天前
已完结
Artificial intelligence in drug discovery — what it is, where we stand and the path forward
3天前
已完结
The value of patient-focused drug development
3天前
已完结
HPR27 US Food and Drug Administration Approvals, Regulatory Pathways, and Review Time of New Drugs and Biologics, 1980–2024
11个月前
已完结
HPR27 US Food and Drug Administration Approvals, Regulatory Pathways, and Review Time of New Drugs and Biologics, 1980–2024
11个月前
已完结
Reforming the Prescription Drug User Fee Program
1年前
已完结
Impact of Rule 11 on the European Medical Software Landscape: Analysis of EUDAMED and Further Databases Three Years After MDR Implementation
1年前
已完结
皖公网安备34019202002308
